Dr. Cammack is a pharmacologist who has over 20 years of experience in biologics, combination products, and medical products.
As President and Chief Compliance Officer, Dr. Cammack provides overall strategic direction and leadership of activities at Nevakar to ensure compliance with GLP, GCP and GMP regulations, and other applicable global regulatory requirements and Quality and Compliance Standards.
Prior to joining Nevakar, he served as the Global Vice President of Development Quality for AstraZeneca’s biotech businesses. Additionally, he has held leadership positions in large and small pharma/biotech companies and co-founded a risk management consulting firm.
Dr. Cammack is an advisory board member of Northwestern University’s Center of Excellence in Nanotechnology Cancer Research, and the Biotechnology program at the University of Illinois Medical School.
Dr. Cammack received a BS in Chemistry from University of Central Missouri and a PhD in Pharmacology from the University of Kansas.